Abstract
Introduction
Gastric cancer is one of the most common malignancies in tumours in East Asian countries [1] [2] . Like [3] . Currently, more than several hundred unique mature human miRNAs are known (http://microrna. [4] or tumour suppressors [5] . Previously, altered miRNA expression signature is observed in gastric cancers that have been collected from different study cohorts [6] [7] 
sanger.ac.uk). Aberrant expression of miRNAs has been reported to be involved in tumourigenesis, acting, as one might expect, variously as either oncogenes

RNA extraction and quantitative real-time polymerase chain reaction
Stem-loop reverse transcription for mature miRNA was performed as described previously [8] . All reagents were obtained from Applied Biosystems (Foster City, CA, USA). For miRNA detection, mature miR-107 was reverse-transcribed with specific RT primers, quantified with a TaqMan probe. The small nuclear U6 RNA was used as an internal control for normalization and quantification the miRNAs expression as previously reported [9] . 
Cell lines and cultures
Plasmid construction and cell transfection
Transient CMV-driven miRNA sponge backbones and a control sponge containing tandem non-targeting binding sites was identical to that utilized previously [9] . 
Luciferase reporter assay
HEK 293T cells were grown in 10% FBS in DMEM to 80-90% confluence in 24-well plates. Cells were co-transfected with 100 ng firefly luciferase reporter vector containing the DICER1 3'-UTR (named pGL3-DOCER1-3'-UTR) or its 3'-UTR mutant (named pGL3-DOCER1-3'-UTRmut) and 8 ng of the control vector containing Renilla luciferase, pRL-TK (Promega), in a final volume of 0.5 ml performed with lipofectamine 2000 (Invitrogen). Firefly and Renilla luciferase activities were measured consecutively performed with dualluciferase assays (Promega) 48 hrs after transfection.
Western blot analysis
Results
MiR-107 is up-regulated in gastric cancer and associated with tumour metastasis and worse prognosis
In previous studies [5] [6] 
MiR-107 post-transcriptionally down-regulates DICER1 expression by directly targeting its 3-UTR
To understand the mechanisms by which miR-107 mediate tumour invasion and metastasis, the target prediction program TargetScan [12] , PicTar [13] or miRanda (microrna.org and miRBase) was used to search for predicted direct target genes of miR-107. Among the hundreds targets of miR-107, three genes-CHRD, NF2 and DICER1-were previously implicated as tumour suppressor genes [14] [15] [16] [17] [18] [19] [20] . DICER1 was of particular interest, because its expression has been found to be progressively lost in gastric cancers showing increasing degrees of malignancy [20] . TargetScan and PicTar bioinformatics analysis of the 3Ј-UTRs of DICER1 revealed one putative binding site for miR-107, which is highly conserved across various species (Fig. 3A) . (Fig. S1 ). In conclusion, our results indicated that endogenous DICER1 is direct target of miR-107 in gastric carcinoma. [20] (Fig. 4A) . Remarkably, overexpression of DICER1 can strongly inhibit gastric cancer cell migration and invasion in vitro (Fig. 4B, C) . Tail vein metastatic assay in nude mice also showed that ectopic expression of DICER1 in SGC-7901 cells led to significantly less visible tumours in liver surface (Fig. 4D, both Western blot analysis (Fig. 5A) . Importantly, transwell assays indicated that the knockdown of DICER1 significantly prompted miR-107-knockdown SGC-7901 cells migration and invasion in vitro (Fig. 5B, C ) and in vivo (Fig. 5D) 
To investigate the potential interaction experimentally, the human DICER1 3Ј-UTR was subcloned after the firefly luciferase open reading frame (ORF) and co-transfected into HEK 293T cells with the miR-107-expressing vector (pcDNA-3.1-miR-107). An analogous reporter with point substitutions disrupting the target
Fig. 2 MiR-107 promotes gastric cancer cell invasion and metastasis in vitro and in vivo. (A) The expression level of mature miR-107 in various gastric cancer cell lines was determined using quantitative PCR. (B) MiR-107 sponge inhibition function was assayed in SGC-7901 or MKN-45 cells. Luciferase reporter assays were used to examine the sponge inhibition efficiency. (C, D) Transwell migration assay (C) and Matrigel invasion assay (D) of SGC-7901 or MKN-45 cells transfected with miR-107 sponge or its control retrovirus. Magnification in D2, 200ϫ. (E) Mice were injected with 1ϫ10 6 cells through tail vein. Four weeks later, the mice were sacrificed. The liver tissues were observed with naked eyes and the number of visible tumours in liver surface was counted (E1). The liver tissues were made serial sections before being haematoxylin and eosin dyed and observed under a light microscope (E2). N ϭ 3; error bars represent S.E.M. P-values obtained using a one-sided Student's t-test. P Ͻ 0.05 versus cells transfected with control retrovirus. sites (Fig. 3B) was also co-transfected with pcDNA-3.1-miR107. Our results showed that pcDNA-3.1-miR-107 produced a 60% decrease in relative luciferase activity compared with pcDNA3.1-transfected cells, when the full-length wild-type 3Ј-UTR of DICER1 was present (Fig. 3C). However, the relative luciferase activity did not drop as sharply in UTRs that contained mutant binding sites as in those that contained wild-type binding sites, which indicates that this reduction was sequence-specific (Fig. 3C). To demonstrate that inhibited expression of miR-107 has a direct effect on DICER1 target. We assessed DICER1 protein expression levels after miR-107 inhibition by Western blot. We found that inhibition of miR-107 expression in SGC-7901 and MKN-45 cells increased the protein level of DICER1 (Fig. 3D). Those results really demonstrated that the endogenous DICER1 is direct target of miR-107. To exclude the possibility that DICER1 is regulated by other predicted miRNAs in parallel with miR-107, we used TargetScan, PicTar and miRanda (miRBase) to search all miRNAs predicted to target DICER1. Besides miR-107, six candidate mature miRNAs (miR-103, miR-29a, miR-29b, miR-29c, miR-196a, miR-196b) were commonly predicted to target DICER1 by all of the three algorithms. We then test the expression of six candidate miRNAs (miR-103, miR-29a, miR29b, miR-29c, miR-196a, miR-196b) in gastric cancer tissues and their paired adjacent non-tumour gastric cancer tissues, our results showed that miR-29b, and miR-29c were down-regulated in gastric cancer tissues compared with their paired adjacent non-tumour gastric cancer tissues. However, we did not find any expression differences of miR-103, miR-29a, miR-196a and miR-196b in gastric cancer tissues compared with their paired adjacent non-tumour gastric cancer tissues
DICER1 inhibits gastric cancer cell migration and invasion in vitro and in vivo Previous reports indicated that the expression of DICER1 is decreased during the progression of gastric cancer, especially in © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 MiR-107 post-transcriptionally down-regulates DICER1 expression by directly targeting its 3Ј-UTR. (A) The target site of miR-107 in DICER1 3Ј-UTR is conserved among mammalian species (shown in white). (B) Predicted duplex formation between miR-107 and the targeted DICER1 3Ј-UTR. The DICER1 3Ј-UTR mutant is identical to the wild-type, except that it had four point substitutions (red) disrupting pairing to miR-107 seed. (C) pGL3-DICER1 3Ј-UTR reporter plasmid in which the luciferase coding sequence had been fused to the 3Ј-UTR of DICER1 was co-transfected into HERK 293T cells with pcDNA3.1 or pcDNA3.1-miR-107. Luciferase activity was normalized relative to a simultaneously transfected Renilla expression plasmid. The 3Ј-UTRMut indicates the introduction of alterations into the seed complementary sites shown in Figure 2B. N ϭ 3; error bars represent S.E.M. P-values obtained using a one-sided Student's t-test. P Ͻ 0.05 versus cells transfected with control. (D) Western blots of DICER1 in SGC-7901 or MKN-45 cells after miR-107 sponge or control retrovirus infection. ␤-Actin antibody was used as a internal control. The level of DICER1 protein expression level was indicated by the ratio of DICER1/actin (bottom). Representative of three experiments with similar results. progressive gastric cancers, which indicating DICER1 may play an important role in the development of cancer and the epigenetical regulation involved
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Fig. 1 The expression level of mature miR-103 (A), miR-29a (B), miR-29b (C), miR-29c (D), miR-196a (E), and miR-196b (F) were
